Rising costs and inefficiencies, all too common threads within clinical research. Nearly 80% of studies fail to finish on time and 30% of patients drop out before study completion. Decentralized clinical trials have been hailed as a possible solution, but knowledge on design and implementation strategies is still limited and, according to recent figures by GlobalData, only 5% of clinical trials currently implement decentralized trial components.
In this webinar, we discuss and unpack what true decentralization looks like. We explain how stakeholders can navigate the decentralized-centralized trial continuum and outline the value of a hybrid approach that incorporates the best of both worlds. We also touch upon the importance of patient-centricity and how the industry can reshape the patient’s role from research subject into informed collaborator.
We then take a leap into the future by outlining our 2030 outlook for clinical research, explaining how Blockchain, AI, and Self-Sovereign Identity can be applied today and how these emerging technologies will shape the future clinical trial ecosystem.
Join experts Jeff Rogers, President of Crucial Data Solutions and Hadil Es-Sbai, CEO of Triall if you want to know what the future holds for clinical trials. Don’t miss this opportunity to hear fresh perspectives on the evolving clinical research landscape.
Key Learning Objectives
- Define and implement hybrid clinical trial strategies with an appropriate configuration of DCT tools
- Design patient-centric research that optimises the patient experience
- Identify how to apply blockchain for end-to-end data integrity and risk-mitigation purposes
- Recognise the value of Self-Sovereign Identity for advancing patient data ownership, control, and monetisation
